GlassScriptPhysician profile
Daniela Filardi Guilliam
NPI 1245487800
$2,595.63
in general payments reported to CMS, 2019-2025
27 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $104 · 2022: $531 · 2023: $423 · 2024: $794 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,028.07 | 2022-2025 | Inspire |
| Harmony Biosciences LLC | $375.97 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $167.44 | 2020-2025 | |
| Genzyme Corporation | $154.79 | 2023-2025 | |
| Emd Serono, INC. | $125.63 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.63 | 2020-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $70.51 | 2023-2024 | Dupixent |
| Abbvie INC. | $64.84 | 2022-2024 | |
| Insmed, INC. | $46.49 | 2020-2022 | |
| Baxter Healthcare | $43.84 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Avadel Cns Pharmaceuticals, LLC | $41.20 | 2024-2025 | Lumryz |
| Verona Pharma, INC. | $39.22 | 2025 | Ohtuvayre |
| Ge Healthcare | $34.20 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $29.73 | 2023 | Acthar |
| Pulmonx Corporation | $27.53 | 2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.84 | 2024 | Winrevair |
| Amgen INC. | $22.71 | 2025 | Tezspire |
| Stryker Corporation | $22.19 | 2025 | Flowtriever |
| Mallinckrodt Enterprises LLC | $21.68 | 2019 | |
| Acadia Pharmaceuticals INC | $20.89 | 2019 | |
| Lilly USA, LLC | $20.46 | 2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $16.28 | 2019 | |
| Glaxosmithkline, LLC. | $16.17 | 2024 | Arexvy |
| Resmed Corp | $15.03 | 2023 | |
| Mylan Specialty L.P. | $13.52 | 2020 | |
| Allergan, INC. | $12.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Guilliam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.